NASDAQ-GS · traded in Congress
Vaxcyte, PCVX
$56.90 +0.405 (+0.72%) Sep 25, 2026
Market value$8.5B
P/E ratio-
Analyst target$110.00
52-week range-
Avg volume1,077,071
Dividend yieldN/A
Chart
Congress trades in PCVX
Members of Congress disclosed 3 transactions in PCVX in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 07/16/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 9/4/2026 filing |
| 05/13/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 6/8/2026 filing |
| 05/12/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 6/8/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView. Congressional trades parsed from official House filings. Market information, not investment advice.